Belleri M - Search Results

1

Therapeutic Potential of Anti-Angiogenic Multitarget N,O-Sulfated E. Coli K5 Polysaccharide in Diabetic Retinopathy.

Rezzola S, Dal Monte M, Belleri M, Bugatti A, Chiodelli P, Corsini M, Cammalleri M, Cancarini A, Morbidelli L, Oreste P, Bagnoli P, Semeraro F, Presta M. Rezzola S, et al. Among authors: belleri m. Diabetes. 2015 Jul;64(7):2581-92. doi: 10.2337/db14-1378. Epub 2015 Feb 18. Diabetes. 2015. PMID: 25695948

2

Basic fibroblast growth factor overexpression in endothelial cells: an autocrine mechanism for angiogenesis and angioproliferative diseases.

Gualandris A, Rusnati M, Belleri M, Nelli EE, Bastaki M, Molinari-Tosatti MP, Bonardi F, Parolini S, Albini A, Morbidelli L, Ziche M, Corallini A, Possati L, Vacca A, Ribatti D, Presta M. Gualandris A, et al. Among authors: belleri m. Cell Growth Differ. 1996 Feb;7(2):147-60. Cell Growth Differ. 1996. PMID: 8822198

3

Noncompetitive, chemokine-mediated inhibition of basic fibroblast growth factor-induced endothelial cell proliferation.

Presta M, Belleri M, Vecchi A, Hesselgesser J, Mantovani A, Horuk R. Presta M, et al. Among authors: belleri m. J Biol Chem. 1998 Apr 3;273(14):7911-9. doi: 10.1074/jbc.273.14.7911. J Biol Chem. 1998. PMID: 9525887 Free article.

4

Purine analogue 6-methylmercaptopurine riboside inhibits early and late phases of the angiogenesis process.

Presta M, Rusnati M, Belleri M, Morbidelli L, Ziche M, Ribatti D. Presta M, et al. Among authors: belleri m. Cancer Res. 1999 May 15;59(10):2417-24. Cancer Res. 1999. PMID: 10344752

5

Alterations of blood vessel development by endothelial cells overexpressing fibroblast growth factor-2.

Ribatti D, Gualandris A, Belleri M, Massardi L, Nico B, Rusnati M, Dell'Era P, Vacca A, Roncali L, Presta M. Ribatti D, et al. Among authors: belleri m. J Pathol. 1999 Dec;189(4):590-9. doi: 10.1002/(SICI)1096-9896(199912)189:4<590::AID-PATH461>3.0.CO;2-W. J Pathol. 1999. PMID: 10629563

6

Paracrine and autocrine effects of fibroblast growth factor-4 in endothelial cells.

Dell'Era P, Belleri M, Stabile H, Massardi ML, Ribatti D, Presta M. Dell'Era P, et al. Among authors: belleri m. Oncogene. 2001 May 10;20(21):2655-63. doi: 10.1038/sj.onc.1204368. Oncogene. 2001. PMID: 11420677

7

Fibroblast growth factor-2 antagonist activity and angiostatic capacity of sulfated Escherichia coli K5 polysaccharide derivatives.

Leali D, Belleri M, Urbinati C, Coltrini D, Oreste P, Zoppetti G, Ribatti D, Rusnati M, Presta M. Leali D, et al. Among authors: belleri m. J Biol Chem. 2001 Oct 12;276(41):37900-8. doi: 10.1074/jbc.M105163200. Epub 2001 Jul 25. J Biol Chem. 2001. PMID: 11473122 Free article.

8

Generation of biologically active angiostatin kringle 1-3 by activated human neutrophils.

Scapini P, Nesi L, Morini M, Tanghetti E, Belleri M, Noonan D, Presta M, Albini A, Cassatella MA. Scapini P, et al. Among authors: belleri m. J Immunol. 2002 Jun 1;168(11):5798-804. doi: 10.4049/jimmunol.168.11.5798. J Immunol. 2002. PMID: 12023382

9

Anti-angiogenic activity of the purine analog 6-thioguanine.

Presta M, Belleri M, Vacca A, Ribatti D. Presta M, et al. Among authors: belleri m. Leukemia. 2002 Aug;16(8):1490-9. doi: 10.1038/sj.leu.2402646. Leukemia. 2002. PMID: 12145690

10

Short heparin sequences spaced by glycol-split uronate residues are antagonists of fibroblast growth factor 2 and angiogenesis inhibitors.

Casu B, Guerrini M, Naggi A, Perez M, Torri G, Ribatti D, Carminati P, Giannini G, Penco S, Pisano C, Belleri M, Rusnati M, Presta M. Casu B, et al. Among authors: belleri m. Biochemistry. 2002 Aug 20;41(33):10519-28. doi: 10.1021/bi020118n. Biochemistry. 2002. PMID: 12173939

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

72 results

Search Page

Filters